Genetic factors in pancreatitis

Current Gastroenterology Reports

Volumn 5, Issue 2, 2003, Pages 105-109

  Grendell, James H ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ALPHA 1 ANTITRYPSIN; APROTININ; ARGININE; ASPARAGINE; HISTIDINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; ISOLEUCINE; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSIN; TRYPSINOGEN; TRYPSINOGEN ACTIVATION PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; VALINE; CFTR PROTEIN, HUMAN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (505 511); CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (505-511); PEPTIDE FRAGMENT; PRSS2 PROTEIN, HUMAN;

ACUTE PANCREATITIS; ALCOHOL CONSUMPTION; AMINO ACID SUBSTITUTION; AUTOSOMAL DOMINANT INHERITANCE; CHRONIC PANCREATITIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC POLYMORPHISM; HEREDITY; HUMAN; PANCREAS FUNCTION; PATHOGENESIS; PATHOPHYSIOLOGY; POINT MUTATION; REVIEW; GENETIC PREDISPOSITION; GENETICS; MUTATION; PANCREATITIS; PENETRANCE;

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; PANCREATITIS; PENETRANCE; PEPTIDE FRAGMENTS; POINT MUTATION; TRYPSIN; TRYPSIN INHIBITOR, KAZAL PANCREATIC; TRYPSINOGEN;

EID: 0038644692     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-003-0078-7     Document Type: Review

References (35)

1. Whitcomb DC, Gorry MC, Preston RA, et al.: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996, 14:141-145.
2. Whitcomb DC: Genetic predispositions to acute and chronic pancreatitis. Med Clin North Am 2000, 84:531-547.
3. Gorry MC, Gabbaizedeh D, Furey W, et al.: Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 1997, 113:1063-1068.
4. Sahin-Toth M, Graf L, Toth M: Trypsinogen stabilization by mutation Arg117->His: a unifying pathomechanism for hereditary pancreatitis? Biochem Biophys Res Commun 1999, 264:505-508.
5. O'Reilly DA, Kingsnorth AN: Hereditary pancreatitis and mutations of the cationic trypsinogen gene. Br J Surg 2000, 87:708-717.
6. Nishimori I, Kamakura M, Fujikawa-Adachi K, et al.: Mutations in exons 2 and 3 of the cationic trypsinogen gene in Japanese families with hereditary pancreatitis. Gut 1999, 44:259-263.
7. Witt H, Luck W, Becker M: A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology 1999, 117:7-10.
8. Ferec C, Raguenes O, Salomon R, et al.: Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet 1999, 36:228-232.
9. Teich N, Ockenga J, Hoffmeister A: Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. Gastroenterology 2000, 119:461-465.
10. Teich N, Bauer N, Mössner J, Keim V: Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants. Am J Gastroenterol 2002, 97:341-346.
11. Amann ST, Gates LK Jr, Aston CE: Expression and penetrance of the hereditary pancreatitis phenotype in monozygotic twins. Gut 2001, 48:542-547.
12. Chen JM, Piepoli Bis A, Le Bodic L, et al.: Mutational screening of the cationic trypsinogen gene in a large cohort of subjects with idiopathic chronic pancreatitis. Clin Genet 2001, 59:189-193.
13. Hassan Z, Mohan V, McDermott MF, et al.: Pancreatitis in fibrocalculous pancreatic diabetes mellitus is not associated with common mutations in the trypsinogen gene. Diabetes Metab Rev 2000, 16:454-457.
14. Truninger K, Kock J, Wirth HP, et al.: Trypsinogen gene mutations in patients with chronic or recurrent acute pancreatitis. Pancreas 2001, 22:18-23.
15. Monaghan KG, Jackson CE, KuKuruga DL, Feldman GL: Mutation analysis of the cystic fibrosis and cationic trypsinogen genes in patients with alcohol-related pancreatitis. Am J Med Genet 2000, 94:120-124.
16. Ockenga J, Stuhrmann M, Ballmann M, et al.: Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrrent or chronic idiopathic pancreatitis. Am J Gastroenterol 2000, 95:2061-2067.
17. Rossi L, Whitcomb DC, Ehrlich GD, et al.: Lack of R117H mutation in the cationic trypsinogen gene in patients with tropical pancreatitis from Bangladesh. Pancreas 1998, 17:278-280.
18. Keim V: Genetic risk factors in pancreatic diseases: significance for general practice. Medizinische Klinik 2002, 97:278-284.
19. Lowenfels AB, Maissonneuve P, DiMagno EP, et al.: Hereditary pancreatitis and the risk of pancreatic cancer: International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 1997, 89:442-446.
20. Cavallini G, Tittobello A, Frulloni L, et al.: Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 1996, 335:919-923.
21. Ammann RW, Heitz PU, Klöppel G: Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology 1996, 111:224-231.
22. Witt H, Luck W, Hennies HC, et al.: Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000, 25:213-216.
23. Pfutzer RH, Barmada MM, Brunskill APJ, et al.: SPINK/PSTI polymorphisms act as disease modifiers in familial and chronic pancreatitis. Gastroenterology 2000, 119:615-623.
24. Drenth JP, Te Morsche R, Jansen JB: Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut 2002, 50:687-692.
25. Kaneko K, Nagasaki Y, Furukawa T: Analysis of the human pancreatic secretory trypsin inhibitor gene mutations in Japanese patients with chronic pancreatitis. J Human Genet 2001, 46:293-297.
26. Schneider A, Suman A, Rossi L, et al.: SPINK 1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh. Gastroenterology 2002, 123:1026-1030.
27. Hassan Z, Mohan V, Ali L, et al.: SPINK 1 is a susceptibility gene for fibrocalculous pancreatic diabetes in subjects from the Indian subcontinent. Am J Hum Genet 2002, 71:964-968.
28. Cohn JA, Friedman KJ, Noone PG, et al.: Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998, 339:653-658.
29. Sharer N, Schwarz M, Malone G, et al.: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998, 339:645-652.
30. Noone PG, Zhou Z, Silverman LM, et al.: Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001, 121:1310-1319.
31. Powell JJ, Fearon KCH, Siriwardena AK, Ross JA: Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. Surgery 2001, 129:633-640.
32. Buter A, Beksdale J, Gallagher G, et al.: Microsatellite polymorphism at the human TNF and IL-10 loci in acute pancreatitis [abstract]. Gastroenterology 2000, 118:A195.
33. Galllagher GE, Chong P, Eksdale J, et al.: A candidate gene study in predicted severe acute pancreatitis [abstract]. Gastroenterology 2001, 120:A468.
34. Teich N, Walther K, Bodeker H, et al.: Relevance of variants in serum antiproteinases for the course of chronic pancreatitis. Scand J Gastroenterol 2002, 37:360-365.
35. Dusetti NMJ, Tomasini R, Azizi A, et al.: Expression profiling in pancreas during the acute phase of pancreatitis using cDNA microarrays. Biochem Biophys Res Commun 2000, 277:660-667.